PUK9 Comparative Cost Analysis of Treatment for Renal Anemia with Methoxy Polyethylene-Glycol Erythropoietin Beta (MIRCERA®) Versus Erythropoietin Beta (NEORECORMON®)
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.544
https://www.valueinhealthjournal.com/article/S1098-3015(11)02106-1/fulltext
Title :
PUK9 Comparative Cost Analysis of Treatment for Renal Anemia with Methoxy Polyethylene-Glycol Erythropoietin Beta (MIRCERA®) Versus Erythropoietin Beta (NEORECORMON®)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02106-1&doi=10.1016/j.jval.2011.08.544
First page :
A331
Section Title :
Urinary/Kidney Disorders
Open access? :
No
Section Order :
510